• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Laurus Labs Ltd.
    19 Sep 2025, 12:53PM
    10-year high
    936.45
    1.43%
    Laurus Labs soars 6% in 2 days, market cap tops 50,000 crore; here's why
    Business Standard
    At 11:29 AM, Laurus Labs' stock was quoting 2 per cent higher at 943.15 on the BSE, commanding an m-cap of 50,913 crore, exchange data shows
    Copy LinkShare onShare on Share on Share on
    Laurus Labs Ltd. is trading at high day volume of 2.6M.
    logo
    Unichem Laboratories Ltd.
    19 Sep 2025, 10:40AM
    Demand Notice 52 week low
    496.75
    -1.99%
    Unichem Labs shares drop 5% on 19.49-mn notice from European Commission
    Business Standard
    Unichem Laboratories' stock fell 5 per cent after a demand notice from the European Commission for a fine of Euro 19.49 million
    Copy LinkShare onShare on Share on Share on
    Unichem Laboratories Ltd. has lost -22.04% in the last 6 Months
    logo
    Natco Pharma Ltd.
    18 Sep 2025, 02:52PM
    US FDA Classification
    876.05
    -0.93%
    Natco Pharma surges 5% after USFDA classifies Hyderabad facility as VAI
    Business Standard
    Natco Pharma stock was trading at 884.5, up 3.2 per cent compared to the previous session's close of 857.25 on the NSE
    Copy LinkShare onShare on Share on Share on
    Number of MF schemes decreased from 54 to 47 in Jun 2025 qtr
    logo
    Lupin Ltd.
    18 Sep 2025, 08:25AM
    US FDA Observation
    2056.50
    0.48%
    Lupin Gets US FDA Approval For Generic Lenalidomide Capsules
    Lupin Gets US FDA Approval For Generic Lenalidomide Capsules
    NDTV Profit
    Lenalidomide Capsules are indicated for the treatment of adult patients with Multiple myeloma, in combination with dexamethasone.
    Copy LinkShare onShare on Share on Share on
    Lupin Ltd. has an average target of 2326.00 from 8 brokers.
    Lupin gets USFDA nod for generic cancer drug Lenalidomide capsules
    Business Standard | 18 Sep 2025, 12:05AM 1 more
    Lupin gets US FDA nod for generic drug Lenalidomide in multiple potencies
    Business Standard | 17 Sep 2025, 03:00PM
    logo
    Mankind Pharma Ltd.
    17 Sep 2025, 09:34PM
    2644.50
    0.23%
    Mankind Pharma collaborates with OpenAI to build agile supply chains, research
    Business Line
    Mankind will integrate OpenAI Enterprise across multiple functions, including field force enablement, digital marketing, research and development (R&D), manufacturing, and medical affairs
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 640 to 648 in Jun 2025 qtr.
    logo
    Dr. Reddy's Laboratories Ltd.
    17 Sep 2025
    1323.00
    0.02%
    India's bulk drug makers start preparing for Ozempic patent expiry
    Business Standard
    From local giants Dr Reddy's Laboratories Ltd. to suppliers like Macleods Pharmaceuticals Ltd., Indian firms are preparing to make bulk drugs
    Copy LinkShare onShare on Share on Share on
    Dr. Reddy's Laboratories Ltd. is trading above all available SMAs
    Dr Reddy's launches Tegoprazan for treatment of acid-related disorders in Indian market
    Business Line | 16 Sep 2025 1 more
    Dr Reddy's launches 'Tegoprazan' in India for acid peptic diseases
    Business Standard | 16 Sep 2025
    logo
    Novartis India Ltd.
    16 Sep 2025
    900.20
    -0.01%
    Novartis' Vymada patent revoked, generics likely to cut prices by 70%
    Business Standard
    Novartis lost its Vymada patent in India, enabling generic drugmakers to launch versions that could slash prices by up to 70 per cent and improve access for cardiac patients
    Copy LinkShare onShare on Share on Share on
    Novartis India Ltd. is trading at high day volume of 7816.00000.
    logo
    Gland Pharma Ltd.
    16 Sep 2025
    2015.60
    -0.04%
    Gland Pharma Gets Yes Securities' 'Add' Upgrade; Sees U.S., Cenexi Business as Key Growth Drivers
    Gland Pharma Gets Yes Securities' 'Add' Upgrade; Sees U.S., Cenexi Business as Key Growth Drivers
    NDTV Profit
    Yes Securities views Gland Pharma as a better proxy on US generics in the near term, hence hikes target price.
    Copy LinkShare onShare on Share on Share on
    Gland Pharma Ltd. is trading above all available SMAs
    logo
    Anthem Biosciences Ltd.
    16 Sep 2025
    845.45
    -1.35%
    Anthem Biosciences shares surge 46% since listing amid strong financial growth
    Anthem Biosciences shares surge 46% since listing amid strong financial growth
    Economic Times
    Anthem Biosciences shares have risen significantly since its listing. The company reported strong June quarter results, boosting investor confidence. Capacity expansion for custom synthesis is underway. Anthem plans to increase capacity to 425 kilolitres by September 2025. Two products received approval, expanding the commercial portfolio. Revenue jumped nearly 60% in the June quarter.
    Copy LinkShare onShare on Share on Share on
    Anthem Biosciences Ltd. has gained 48.32% in the last 6 Months
    logo
    Novartis India Ltd.
    15 Sep 2025
    900.20
    -0.01%
    Novartis signs $5.7 bn licensing deal with Monte Rosa Therapeutics
    Business Standard
    Under the agreement, Monte Rosa will receive an upfront payment of $120 million and could earn milestone payments and royalties that lift the total value to as much as $5.7 billion
    Copy LinkShare onShare on Share on Share on
    Novartis India Ltd. is trading at high day volume of 7816.00000.
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • Vms Tmt
    • Sampat Aluminium
    • JD Cables
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd